ESMO 2021: Tyrosine kinase inhibitor prolongs progression-free survival in rare neuroendocrine tumour
The first randomised study in malignant pheochromocytoma and paraganglioma (MPP) has found that sunitinib prolongs…
The first randomised study in malignant pheochromocytoma and paraganglioma (MPP) has found that sunitinib prolongs…
Precision medicine in cancer treatment uses genetic changes in the cancer cells to select the…
A new proof-of-concept study published in the May issue of The Journal of Nuclear Medicine has demonstrated…
The newly developed [55Co]55Co-DOTATATE imaging agent has emerged as a more accurate and sensitive radiopharmaceutical…
Professor Dorothy Keefe, from the University of Adelaide, presented at the Clinical Oncology Society of…